Login / Signup

Cancer-associated prothrombotic pathways: leucocytosis, but not thrombocytosis, correlates with venous thromboembolism in women with ovarian cancer.

Javier López-SalazarLaura A Ramírez-TiradoNora Gómez-ContrerasIrlanda Pacheco-BravoEvelyn CortésDolores GallardoArrieta OscarGabriela Cesarman-Maus
Published in: Internal medicine journal (2021)
Risk factors for venous thromboembolism in cancer vary between tumours. Leucocytosis, thrombocytosis, tumour histology and vascular compression may drive thrombosis in ovarian cancer. Thrombosis developed in 13.4% of our patients. Higher median leucocyte, neutrophil and monocyte counts were related to thrombosis. Thrombocytosis >350 × 109 /L was frequent (63.8%), but not predictive of thrombosis. Identification of prothrombotic biomarkers may help personalise preventive treatments.
Keyphrases